Sigma-Aldrich Prices Senior Notes | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich announced last night that it has priced an aggregate principal amount of $300 million of senior notes due 2020 through a public offering.

The St. Louis-based research products and chemicals firm said that it would use proceeds from the offering for general corporate purposes.

The notes have a 10-year maturity, an issue price of 99.915 percent, and a fixed rate coupon of 3.375 percent, payable semi-annually.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.